Remove Avalon Remove Startup Remove Venture Capital
article thumbnail

Avalon Ventures, GlaxoSmithKline Team On Two New Startups

socalTECH

San Diego-based venture capital investor Avalon Ventures and biopharmaceuticals firm GlaxoSmithKline said Monday that the two have teamed up to fund and launch up to 10, early stage life science companies. According to Avalon Ventures and GSK, they will provide up to $495M to fund those ten new companies.

Avalon 100
article thumbnail

Avalon Ventures Backs Pingup

socalTECH

Avalon Ventures , the La Jolla- and Cambridge-based venture capital firm, has backed a new startup, Pingup , which lets consumers text nightclubs for reservations and information. According to Pingup Tuesday, it raised $1M in a seed funding round from Avalon Ventures, led by Brady Bohrmann.

Avalon 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Avalon Ventures Raises $201.6M As Part Of $250M Venture Fund

socalTECH

In what is a rarity nowadays for a Southern California venture capital fund, San Diego- and Cambridge-based venture capital firm Avalon Ventures has just closed on $201.6M in commitments for a $250M fund, Avalon Ventures X. The funding was disclosed via a regulatory filing Thursday.

Avalon 184
article thumbnail

Avalon Ventures: Startups Get Milestone Payments, New Company Launched With GSK

socalTECH

San Diego-based Avalon Ventures , and COI Pharmaceuticals , the company established by Avalon to help form new biotech companies, said today that the first two companies that it has formed with GlaxoSmithKline have met their first milestones, and that it has spun up a new company with GSK as part of their collaboration.

Avalon 113
article thumbnail

Avalon Ventures Launches Trio Of Life Science Startups

socalTECH

San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.

Avalon 100
article thumbnail

Southern California Startups Raise $761.12M in Q2 2014

socalTECH

The latest venture capital totals from the PricewaterhouseCoopers/National Venture Capital Association''s MoneyTree Report was released this evening, tallying up $761.12M in investments in Q2 of 2014 in Southern California, up from Q2 of 2013, when $616.83M was invested in the region.

article thumbnail

After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma

Xconomy

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56